SEC Tracker
Get the app

Passage BIO PASG

Passage BIO merges with Remix

Merger registration (amended)

Form
S-4/A
Filed
Importance
Routine
  1. Amended merger agreement dated Sept 2, 2026
  2. Merger exchange ratio of 0.1727 shares
  3. Concurrent financing of $100M expected
  4. Reverse stock split ratio 1-for-2 to 1-for-10

Written from the S-4/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Passage BIO files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Pulmatrix PULM public float $25M, Jun 30, 2025
  2. Scynexis SCYX public float $26M, Jun 30, 2025
  3. Palatin Technologies PTN public float $26M, Dec 31, 2025
  4. Curis CRIS public float $25M, Jun 30, 2025
  5. Kala Bio KALA public float $25M, Jun 30, 2025